Global Women Health Market Size [2021-2028] | is Projected to Reach USD 41.05 Billion by 2027, Exhibiting a CAGR of 3.2%
December 09, 2021 05:40 ET
|
Fortune Business Insights
Pune, India, Dec. 09, 2021 (GLOBE NEWSWIRE) -- The global Women Health Market size is projected to reach USD 41.05 billion by 2027, exhibiting a CAGR of 3.2% during the forecast period. The COVID-19...
New 'E Woman' App Helps Women Connect, Manage Stress During Holidays and Every Day
December 07, 2021 08:00 ET
|
E Woman
NASHVILLE, Tenn., Dec. 07, 2021 (GLOBE NEWSWIRE) -- According to the American Psychological Association, holidays create tension when people deal with unrealistic expectations, financial...
Agile Therapeutics to Participate in Upcoming Investor Conferences
September 07, 2021 07:30 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that management will present and participate at the...
Menotropin Market Sales are Expected to Grow at a CAGR of 5.5% through 2031
July 01, 2021 11:35 ET
|
insightSLICE
PUNE, India, July 01, 2021 (GLOBE NEWSWIRE) -- The Global Menotropin Market Share, Trends, Analysis and Forecasts, 2021-2031 provides insights on key developments, business strategies, research...
New Features in Exa Mammo Designed to Address Quality Assurance and Improve Communication
April 03, 2019 09:00 ET
|
Konica Minolta Healthcare Americas, Inc.
WAYNE, N.J., April 03, 2019 (GLOBE NEWSWIRE) -- Konica Minolta Healthcare Americas, Inc., will highlight new features of Exa® Mammo, a PACS designed for breast imaging centers. Exa Mammo enables...
Agile Therapeutics Reports Additional Phase 3 SECURE Study Results Relating to Twirla® at ACOG 2017
May 06, 2017 14:05 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., May 06, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (NASDAQ:AGRX), a women’s healthcare company, today announced the presentation of additional results of its Phase 3 SECURE...
Agile Therapeutics Announces Presentation of SECURE Phase 3 Data at the 2017 Congress on Women’s Health
April 27, 2017 07:30 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., April 27, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (NASDAQ:AGRX), a women's healthcare company announced today that a presentation entitled “An Update on Hormonal...
Agile Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results
March 08, 2017 16:15 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., March 08, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's health specialty pharmaceutical company today reported financial results for the three months...
Agile Therapeutics Reports Third Quarter Financial Results
November 09, 2015 16:10 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Nov. 09, 2015 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's health specialty pharmaceutical company focused on the development and commercialization of new...
Agile Therapeutics Announces Completion of Patient Enrollment in Twirla(R) Phase 3 SECURE Clinical Trial
October 19, 2015 16:08 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Oct. 19, 2015 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX) a women’s health specialty pharmaceutical company focused on the development and commercialization of...